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1. Introduction 
As a result of X-ray crystallographic studies, it is 
becoming evident that similar structural domains for 
the binding of mononucleotide units are present in a 
variety of enzymes. A basic mononucleotide structural 
unit is present twice in the NAD-binding domain of 
dehydrogenases, and is also present in several kinases 
(for reviews, see [l] and [2] ). The adenosine moiety 
of the coenzyme is bound in a hydrophobic pocket at 
one end of the binding crevice, which appears to be a 
general hydrophobic cleft for the binding of an 
aromatic molecule. As stated by Blake and Evans [3], 
the possibility of an evolutionary relationship in the 
nucleotide binding units of dehydrogenases and 
kinases further suggests that other classes of enzyme 
may also contain this basic unit. Indirect evidence, 
based on the interaction of several proteins with blue 
dextran-Sepharose columns [4,5], has also led to the 
prediction that structural features resembling the 
NAD-binding domain are present in many enzymes of 
yet unknown three-dimensional structure. Among 
those enzymes mentioned by Stellwagen and coworkers 
[4,5] are two enzymes, such as phosphorylase a and 
Fru-P2ase, which bind a mononucleotide (AMP) at an 
allosteric site. 
Einarsson et al. [6] have elegantly demonstrated 
by X-ray crystallography that salicylate, a general 
coenzyme competitive inhibitor of dehydrogenases 
[7], binds in the hydrophobic adenosine-binding 
pocket of alcohol dehydrogenase in a manner entirely 
similar to adenosine, in spite of their very different 
structures. The above finding led them to suggest hat 
Abbreviations: Fru-P,ase, fructose 1,6-bisphosphatase; 
NBS,, 5,5’-dithiobis (2-nitrobenzoic acid). 
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salicylate may act as a specific inhibitor of additional 
enzymes having similar binding domains. Therefore, 
if the allosteric site of Fru-P*ase has structural 
features similar to the adenosine-binding domain of 
dehydrogenases, one should be able to demonstrate 
that salicylate interacts at the allosteric AMP site of 
Fru-Passe. The present work provides evidence of this 
interaction. 
2. Materials and methods 
Pig kidney Fru-P,ase with optimal activity at 
neutral pH was purified as previously described [8], 
with an additional final step involving heating 5 min 
at 62°C. The purified enzyme showed a single protein 
band (mol. wt 35 000) in polyacrylamide disc-gel 
electrophoresis in the presence of sodium dodecyl 
sulfate. Its protein concentration was determined by 
its absorbancy at 280 nm using the extinction 
coefficient E{Frn of 7.55 [9]. The molecular weight 
of the enzyme tetramer was taken as 140 000 for all 
calculations. Fru-P*ase activity was measured spectro- 
photometrically as described [lo] . The assays were 
carried out at 30°C in a reaction system which 
contained 50 mM N-2-hydroxyethylpiperazine-N’- 
2-ethanesulfonic acid (Hepes)-NaOH buffer (pH 7.5), 
0.17 mM fructose 1,6-bisphosphate (Sigma stock 
750-l) 5 mM MgS04, 0.1 mM EDTA, 0.3 mM NADP, 
phosphoghrcose isomerase (2.3 U/ml), glucose-6-P 
dehydrogenase (0.6 U/ml), and other additions as 
indicated. The reaction was initiated by the addition 
of fructose 1,6-bisphosphate. 
Chemical modification reactions were performed 
under the conditions given in the figure and table 
legends. 5-Iodosalicylic acid (Aldrich) was recrystallized 
several times from 25% (v/v) acetone-water. Salicylic 
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(Eastman Kodak) and iodosalicylic acid solutions were 
neutralized with NaOH. 
3. Results and discussion 
Experiments on the effect of salicylate on Fru- 
Pzase activity showed that salicylate (up to 20 mM) 
had no effect on the activity of the enzyme. How- 
ever, the presence of salicylate resulted in a significant 
relief of allosteric AMP inhibition (fig.1). Iodo- 
substituted salicylate proved to be more effective in 
diminishing AMP inhibition of Fru-P*ase. The effect 
of 2 mM Siodosalicylate on AMP inhibition (fig.1, 
filled circles) was similar to that obtained with 10 mM 
salicylate. These results are entirely consistent with 
the binding data of salicylates in the adenosine-binding 
pocket of liver alcohol dehydrogenase [6] , and suggest 
that salicylates also interact at the AMP site of Fru-Pzase. 
To test further whether AMP and salicylate bind 
at the same site on the enzyme, chemical modification 
experiments were performed. Previous reports have 
already demonstrated that, under certain experimental 
conditions, the AMP inhibition of Fru-P,ase can be 
decreased or nearly abolished by means of chemical 
modification of the enzyme with pyridoxal-P [9,11, 
121. The loss of AMP inhibition can be prevented by 
the presence of AMP in the modification reaction 
system. Thus, if salicylate binds at the AMP site, it 
should also protect from loss of AMP inhibition. As 
shown in table 1, iodosalicylate afforded considerable 
)A4 AMP 
Fig.1. Effect of salicylate on the inhibition of fructose 
1,6-bisphosphate by AMP. Enzyme activity was determined 
as described under Materials and methods, except for the 
variable AMP concentration (as indicated in the abscissa), 
and sodium salicylate (O-20 mM) as shown. The results 
indicated by jiZled circles (0) correspond to the activity of 
the enzyme measured in the presence of 2 mM iodosalicylate, 
and AMP as indicated in the abscissa. 
Table 1 
Effect of iodosalicylate on modification of fructose 1,6-bisphosphatase by pyridoxal-P 
Enzyme treatment 
Specific 
activity 
Percent 
inhibition 
by 67 I.~M AMP 
Pyridoxyl-P 
incorporated 
(mol/mol) 
1. 
2. 
3. 
4. 
5. 
None 
NaBH, control 
Modified 
Modified in the presence 
of 10 mM iodosalicylate 
Modified in the presence 
of 0.5 mM AMP 
13.3 93 _ 
12.8 91 _ 
10.8 24 3.5 
10.4 71 2.6 
12.3 93 2.2 
Modification of Fru-P,ase with pyridoxal-P was performed in a reaction system containing 
100 mM sodium borate buffer (pH 8.0), 165 mM KCl, 66 PM EDTA, 1 mM fructose 
1,6_bisphosphate, 8 mM pyridoxal-P, 7.3 rM Fru-P,ase and other additions as indicated. 
Incubation was at 4”C, and after 18 min, the reaction was stopped with NaBH, (for 
additional details, see [ 121). The control enzyme (exp. 2) was subjected to the same 
treatments, except for the omission of pyridoxal-P 
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protection against loss of AMP inhibition by 
pyridoxal-P treatment and measurements of the 
incorporation of pyridoxal-P into the protein demon- 
strate that iodosalicylate (as does AMP) also decreases 
the incorporation of reagent into Fru-P*ase. 
If salicylate binds at the AMP site, as it appears to 
do from the above results, it still remains to be 
explained why it does not act as an inhibitor of 
Fru-P*ase. A likely explanation can be suggested if
one considers that the inhibition of an enzyme by an 
allosteric inhibitor involves (in its simplest form) at 
least two steps: (a) binding of the inhibitor at the 
allosteric site; followed by (b) a conformational 
change of the protein which results in an unfavorable 
alignment of either substrate binding or catalytic 
groups at the active site. Thus, in this simple scheme, 
salicylate could bind at the allosteric site but might 
not induce the conformational change that results in 
inhibition of enzyme activity. To test the above 
possibility, advantage has been taken of an 
unexplored feature of the titration of SH groups of 
Fru-P*ase with NBSa . Previous reports on the 
titration of various Fru-Pzases with an excess NBS* 
(see [ 131 and references cited therein) have shown 
the very fast reaction of 4 SH groups per molecule 
(i.e., 1 subunit) of enzyme, followed by (depending 
on the reaction conditions) a much slower reaction 
of further SH groups. However, no attempt has been 
made to limit the reaction to only the fast reacting 
SH groups by using stoichiometric amounts of NBS?. 
Using this approach, it was found that the reactivity 
of the fast reacting SH (fig.2A, empty circles) is 
dramatically increased by the presence of AMP (fig.2A, 
empty squares), which is most likely the reflection of 
an AMP-induced enzyme conformational change. 
Conversely, iodosalicylate does not alter the SH 
reactivity (tig.2A, filled circles), in accordance with 
its inability to inhibit the activity of the enzyme. 
Fig.2A. Reaction of fructose 1,6-bisphosphatase with NBS,. Enzyme (1.1 ecM) was allowed to react at 28°C with 4.4 ctM NBS, 
in a reaction system containing 60 mM Tris-HC1 buffer (pH 7.5), 25 mM KCl, 120 PM EDTA, and other additions as indicated 
below. (o), No other additions; (o), plus 33 PM AMP; (a), plus 2 mM iodosalicylate; (=), plus 33 PM AMP and 2 mM iodosalicylate. 
Titration of enzynie SH groups was followed by the rate of formation of the thionitrobenzoate anion at 412 nm with a Cilford 
Model 2000 spectrophotometer. Reactions were always started by the addition of NBS,. A molar extinction coefficient of 
13 600 for the liberated thionitrobenzoate anion was used for all calculations [ 141. Fig.ZB. Second-order ate constants for the 
titration of the SH group with NBS,. Data obtained from fig.ZA were plotted as l/C against ime, applicable for this special 
case in which the concentrations of A (NBS,) and B (reactive SH) at zero time are identical. The rate law is then given by the 
equation l/C - l/C, = kt, in which C is the remaining concentration of A or B at any time [ 151. Second-order ate constants (k) 
are given in the figure. 
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However, iodosalicylate competes with AMP since 
in the presence of both (fig.2A, filled squares) the SH 
reactivity is intermediate to that found with and 
without AMP. The second-order rate constants for the 
titration of the SH group with NBS2 are given in 
fig.2B. Experiments with salicylate, instead of iodo- 
salicylate, gave essentially the same type of result. 
The rate constant for the titration of the SH group 
was 20 min-’ mM_’ . m the presence of 8 mM salicylate, 
and 33 min-’ mM_’ . m the presence of 8 mM salicylate 
plus 33 PM AMP. 
In conclusion, the results presented herein provide 
evidence for the interaction of salicylate with Fru- 
Pzase and that this interaction most likely occurs at 
the AMP site. Based on previous knowledge of the 
interaction of salicylate with alcohol dehydrogenase 
[6] , and related evidence (for details, see refs. [l--5] ), 
it may be tentatively suggested that the allosteric site 
of fructose 1,6-bisphosphatase has structural features 
similar to the adenosine-binding domain of dehydro- 
genases and kinases. 
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